Preferred Label : Cutis laxa, autosomal recessive, type iia;
Symbol : ARCL2A;
CISMeF acronym : ARCL2A; ARCL2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Cutis laxa with bone dystrophy; ARCL2; Cutis laxa with congenital disorder of glycosylation; Cutis laxa with joint laxity and retarded development; Cutis laxa, debre type; Cutis laxa with growth and developmental delay;
Description : Autosomal recessive cutis laxa type II represents a spectrum of clinical entities
with variable severity of cutis laxa, abnormal growth, developmental delay, and associated
skeletal abnormalities. Aside from cutis laxa, persistent wide fontanels, frontal
bossing, slight oxycephaly, downward-slanted palpebral fissures, reversed-V eyebrows,
and dental caries are characteristic. Patients with ARCL2 can be divided into 2 major
groups: ARCL2A, comprising those with a combined N- and O-linked glycosylation defect
(CDG type II), and ARCL2B, those without a metabolic disorder (summary by Morava et
al., 2009). Van Maldergem et al. (2008) concluded that ARCL2A should be considered
more of a multisystem disorder with cobblestone-like brain dysgenesis manifesting
as developmental delay and an epileptic neurodegenerative syndrome rather than purely
a dermatologic disorder. For a phenotypic description and a discussion of genetic
heterogeneity of autosomal recessive cutis laxa, see ARCL1A (219100). - Genetic Heterogeneity
of Cutis Laxa Type II;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the ATPase, H transporting, lysosomal, V0 subunit A2 gene (ATP6V0A2,
611716.0001);
Laboratory abnormalities : Abnormal isoelectric focusing of serum transferrin; Defect in N- and O-glycosylation;
Prefixed ID : #219200;
Origin ID : 219200;
UMLS CUI : C0268355;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT